During the past decade, CH de Marne la Vallée conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH de Marne la Vallée" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 3 trials, followed by "Centre Hospitalier Intercommunal Creteil" with 1 trials sponsored, "LivaNova" with 1 trials sponsored, "MicroPort CRM" with 1 trials sponsored and "Terumo Europe N.V." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Marne la Vallée" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Association Clinique Thérapeutique Infantile du val de Marne" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator, "Francophone Pediatric Resuscitation and Emergency Group (GFRUP)" with 1 trials as a collaborator and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "CH de Marne la Vallée" are "Arrythmia" (1 trials), "COVID" (1 trials), "COVID-19" (1 trials), "CRT Patients" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "CH de Marne la Vallée" in a lesser frequency.

Most popular intervention types in "CH de Marne la Vallée" are "Drug" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "FOLFIRI.3" (1 trials), "FOLFIRINOX" (1 trials), "FOLFOX4 or XELOX" (1 trials), "Gemcitabine" (1 trials) and "ICD" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH de Marne la Vallée" are 7 trials for "All" genders.

Currently, there are NaN active trials in "CH de Marne la Vallée". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CH de Marne la Vallée, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CH de Marne la Vallée, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".